Islet Cell Cancer

Research

Mayo Clinic is a leader in developing innovative therapies and treatments for islet cell cancer. Its active clinical trial program studies diagnostic methods, treatment options, and symptom management. Mayo physicians apply the research findings to treatment.

Mayo Clinic's research aligns strongly with the research programs of the Mayo Clinic Cancer Center. This alignment makes it possible for patients to enroll in cutting-edge clinical cancer research studies, receive the most advanced treatments, and learn about their illness to actively participate in decisions about their treatment. Mayo patients have the opportunity to participate in numerous clinical trials of experimental therapies.

Clinical Trials

For a list of clinical trials involving patients at Mayo Clinic, see the Clinical Trials Web page. It lists clinical trials by condition, treatment, specialty and Mayo Clinic location.

This list includes only trials about which Mayo researchers have chosen to publish information. Other trials may be under way. Ask your doctor about clinical trials appropriate for your situation.

Publications

Ansell SM, Mahoney MR, Green EM, Rubin J. Topotecan in patients with advanced neuroendocrine tumors: a phase II study with significant hematologic toxicity. Am J Clin Oncol. 2004 Jun;27(3):232-5. [Abstract]

Ansell SM, Pitot HC, Burch PA, Kvols LK, Mahoney MR, Rubin J. A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors. Cancer. 2001 Apr 15;91(8):1543-8. [Abstract]

Hobday T.J., et al. Preliminary results of a phase II trial of gefitinib in progressive metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study. Proc Am Soc of Clin Oncol. 2005 (In Press). [No Abstract Available]

Hobday T.J., Rubin J., Goldberg R., Erlichman C., Lloyd R. Molecular markers in metastatic gastrointestinal neuroendocrine tumors. Proceedings of ASCO (Poster Session) 2003; volume 22:1078. [No Abstract Available]

Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003 Jul;197(1):29-37. [Abstract]

See a list of publications by Mayo doctors on islet cell cancer on PubMed, a service of the National Library of Medicine.